Shanghai Green Valley Pharmaceuticals
China’s new seaweed-based Alzheimer’s therapy raises hopes—and questions about safety, effectiveness
Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, potentially shaking up the field ...
